# Nitric Oxide Effect on Brain and Kidney in Pediatric Patients Undergoing Cardiopulmonary Bypass

> **NCT05101746** · PHASE2,PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Vanderbilt University Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Congenital Heart Disease
- Congenital Heart Defect
- Congenital Heart Malformations

## Interventions

- **DRUG:** Nitric Oxide (NO) 20 part per million (ppm)
- **OTHER:** Standard of care cardiopulmonary bypass

## Key facts

- **NCT ID:** NCT05101746
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-04-25
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05101746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05101746, "Nitric Oxide Effect on Brain and Kidney in Pediatric Patients Undergoing Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05101746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*